Vaccine Adverse Reaction
49
1
6
25
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.1%
2 terminated out of 49 trials
92.6%
+6.1% vs benchmark
18%
9 trials in Phase 3/4
8%
2 of 25 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 25 completed trials
Clinical Trials (49)
Genomics and COVID-19 Vaccine Adverse Events
Immunogenicity and Safety of Recombinant Zoster Vaccine in People Living With HIV
Effectiveness, Immunogenicity and Safety of the Second Booster Dose of the Vaccine Against COVID-19 in the Elderly
Clinical Trial Phase I/IIa to Evaluate the Safety and Immunogenicity of StreptInCor
Immunogenicity and Safety Following In-House Recombinant Hepatitis B Vaccine in Indonesian Population (Phase III)
Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine in Healthy Children
Effect of Metabolic Modulation on a Post-acute COVID-19 Vaccination Syndrome (PACVS) Cohort
Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants
A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised Adults
Peri-conceptional or Pregnancy Exposure of Vaccination and the Risk of Adverse Pregnancy Outcomes
Study of Sputnik V COVID-19 Vaccination in Adults in Kazakhstan
Vaccine Observation to Include All Communities for Equitable Science
COVID19 Vaccine in SOT Adult Recipients
Evaluation of the Immunogenicity and Safety of Ad26.COV2.S's COVID-19 Vaccine
Evaluation of the Immunogenicity and Safety BBIBP-CorV Vaccine for COVID-19 in Adults in Guinea
Immunological Safety and Effectiveness of the First Booster Dose of mRNA Vaccines Against COVID-19 in Kidney Transplant Recipients.
Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza
Expectations About the COVID-19 Vaccines
Immunogenicity, Efficacy and Safety of QazCovid-in® COVID-19 Vaccine
Reactogenicity, Safety and Immunogenicity of QazCoVac-P COVID-19 Vaccine